• About us
• Contact

Advertisement

Organisation › Details

Fluidigm Japan K.K.

Fluidigm (Nasdaq:FLDM) focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF® and microfluidics technologies, we develop, manufacture, and market multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies. Our customers are leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide. Together with them, we strive to increase the quality of life for all. *

 

	Start	2014-01-30 existent
	Group	Fluidigm (Group)
	Industry	single cell analysis
	Industry 2	cell analysis technology
	Region	Tokyo
	Country	Japan
	Street	Lumious 4F, Nihonbashi-Kodenmacho Chuo-ku
	City	103-0001 Tokyo
	Tel	+81-3-3662-2150
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«: Fluidigm Corporation. (4/1/22). "Press Release: Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion". South San Francisco, CA.
		Record changed: 2023-07-10

Advertisement

More documents for Fluidigm (Group)

• [1] Fluidigm Corporation. (4/1/22). "Press Release: Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion". South San Francisco, CA....
• [2] Fluidigm Corporation. (3/28/22). "Press Release: Fluidigm Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financing Solution". South San Francisco, CA....
• [3] Fluidigm Corporation. (1/24/22). "Press Release: Fluidigm Announces $250 Million Strategic Capital Infusion from Casdin Capital and Viking Global Investors and Rebranding to Standard BioTools Inc.". South San Francisco, CA....
• [4] Fluidigm Corporation. (9/2/21). "Press Release: Fluidigm to Participate in the Cantor Virtual Global Healthcare Conference". South San Francisco, CA....
• [5] Fluidigm Corporation. (5/7/20). "Press Release: Fluidigm Announces First Quarter 2020 Financial Results". South San Francisco, CA....
• [6] Fluidigm Corporation. (5/7/20). "Press Release: Fluidigm Expands Accessibility of Mass Cytometry and Imaging Mass Cytometry Technology with New Therapeutic Insights Services". South San Francisco, CA....
• [7] Fluidigm Corporation. (3/16/20). "Press Release: Consortium of Medical Schools Led by Mount Sinai Fast-Tracking COVID-19 Detection Test Utilizing Fluidigm Microfluidics Technology". South San Francisco, CA....
• [8] Fluidigm Corporation. (3/10/20). "Press Release: Fluidigm Introduces AccuLift Laser Capture Microdissection System to Advance Translational and Clinical Pathology Research". South San Francisco, CA....
• [9] Fluidigm Corporation. (3/3/20). "Press Release: Fluidigm and Next Gen Diagnostics Enter into Agreement to Improve the Efficiency of Pathogen Sample Preparation for Microbial Whole Genome Sequencing". South San Francisco, CA & Hinxton....
• [10] Fluidigm Corporation. (2/26/20). "Press Release: Fluidigm Completes Acquisition of InstruNor AS". South San Francisco, CA....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2023. Made in Germany.